Literature DB >> 19047545

Suitability of forced expiratory volume in 1 second/forced vital capacity vs percentage of predicted forced expiratory volume in 1 second for the classification of asthma severity in adolescents.

Christine van Dalen1, Elizabeth Harding, Jill Parkin, Soo Cheng, Neil Pearce, Jeroen Douwes.   

Abstract

OBJECTIVE: To determine whether lung function alters asthma severity based on symptom history in asthmatic adolescents.
DESIGN: Data on asthma symptoms and lung function were collected from adolescents randomly selected from the general population.
SETTING: Five schools from the central Wellington, New Zealand, area during 2003 to 2005. PARTICIPANTS: Two hundred twenty-four secondary school students aged 13 to 17 years (asthmatic, 118; nonasthmatic, 106). MAIN EXPOSURES: Asthma questionnaire and lung function testing. MAIN OUTCOME MEASURES: Distribution of asthmatic adolescents in each severity class based on symptoms, lung function, or a combination of both.
RESULTS: Median values for all spirometric parameters for asthmatic adolescents, apart from forced expiratory volume in the first second of expiration (FEV(1))/forced vital capacity (FVC), were in the normal range. Distribution of severity (based on symptoms and beta(2)-agonist use with adjustment for regular inhaled corticosteroid use) was 48.3%, mild; 28.8%, moderate; and 22.9%, severe asthma. For severity based on percentages of predicted FEV(1) and predicted forced expiratory flow, midexpiratory phase (FEF(25%-75%)) and FEV(1)/FVC, the percentages were 89.8%, 86.4%, and 63.5%, mild; 9.3%, 10.2%, and 18.6%, moderate; and 0.9%, 3.4%, and 17.8%, severe asthma, respectively. When percentages of predicted FEV(1) or predicted FEF(25%-75%) or FEV(1)/FVC were added to symptom severity, 6.8%, 5.1%, and 16.9% of asthmatic adolescents were reclassified into another severity group, respectively.
CONCLUSIONS: The majority of asthmatic adolescents have normal lung function despite experiencing significant asthma symptoms. Adding FEV(1)/FVC to symptom history changes the distribution of severity; however, both percentages of predicted FEV(1) and FEF(25%-75%) have little added effect in assessing asthma severity in adolescents.

Entities:  

Mesh:

Year:  2008        PMID: 19047545     DOI: 10.1001/archpedi.162.12.1169

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  8 in total

Review 1.  Management of severe asthma in children.

Authors:  Andrew Bush; Sejal Saglani
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

2.  Differences in spirometry values between U.S. children 6-11 years and adolescents 12-19 years with current asthma, 2007-2010.

Authors:  Brian K Kit; Alan E Simon; Timothy Tilert; Sande Okelo; Lara J Akinbami
Journal:  Pediatr Pulmonol       Date:  2015-07-07

3.  Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids.

Authors:  Heung-Woo Park; Amber Dahlin; Szeman Tse; Qing Ling Duan; Brooke Schuemann; Fernando D Martinez; Stephen P Peters; Stanley J Szefler; John J Lima; Michiaki Kubo; Mayumi Tamari; Kelan G Tantisira
Journal:  J Allergy Clin Immunol       Date:  2014-01-31       Impact factor: 10.793

4.  Genetic biomarkers of health-related quality of life in pediatric asthma.

Authors:  Sandra D Cortina; Dennis Drotar; Mark Ericksen; Mark Lindsey; Tia L Patterson; Jocelyn M Biagini Myers; Melinda Butsch Kovacic; Gurjit K Khurana Hershey
Journal:  J Pediatr       Date:  2011-02-15       Impact factor: 4.406

Review 5.  High-altitude alpine therapy and lung function in asthma: systematic review and meta-analysis.

Authors:  Denis Vinnikov; Abdullah Khafagy; Paul D Blanc; Nurlan Brimkulov; Craig Steinmaus
Journal:  ERJ Open Res       Date:  2016-06-06

6.  Correlations of smoking with cumulative total dust exposure and cumulative abnormal rate of pulmonary function in coal-mine workers.

Authors:  Qing-Zeng Qian; Xiang-Ke Cao; Fu-Hai Shen; Qian Wang
Journal:  Exp Ther Med       Date:  2016-09-13       Impact factor: 2.447

7.  Factors influencing negative surgical outcomes in adult pectus excavatum patients undergoing Nuss procedure.

Authors:  Zhen Gao; Shujie Huang; Yong Tang; Sichao Wang; Weitao Zhuang; Yu Ding; Hansheng Wu; Jiming Tang; Dongkun Zhang; Haiyu Zhou; Xiaosong Ben; Liang Xie; Gang Chen; Guibin Qiao
Journal:  Ann Transl Med       Date:  2021-08

8.  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Loki zupa in Patients With Chronic Asthma.

Authors:  Yubao Lv; Ying Wei; Muhammadjan Abduwaki; Tohti Jurat; Fengsen Li; Huaizhen Wang; Yuhua Wu; Zheng Li; Bo Liu; Hongjun Yin; Yuxue Cao; Mammat Nurahmat; Zihui Tang; Jingcheng Dong
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.